Advancing mRNA technologies for therapies and vaccines: An African context.

Kairuz, Dylan; Samudh, Nazia; Ely, Abdullah; Arbuthnot, Patrick; Bloom, Kristie

Kairuz, Dylan; Samudh, Nazia; Ely, Abdullah; Arbuthnot, Patrick; Bloom, Kristie.

Afiliação

Kairuz D; Wits/SAMRC Antiviral Gene Therapy Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Samudh N; Wits/SAMRC Antiviral Gene Therapy Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Ely A; Wits/SAMRC Antiviral Gene Therapy Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Arbuthnot P; Wits/SAMRC Antiviral Gene Therapy Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Bloom K; Wits/SAMRC Antiviral Gene Therapy Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Front Immunol ; 13: 1018961, 2022.

Article em En | MEDLINE | ID: mdl-36353641

Assuntos

COVID-19; Vacinas; Humanos; RNA Mensageiro/genética; Vacinas contra COVID-19; COVID-19/prevenção & controle; Tecnologia

Palavras-chave

African vaccine development; lipid nanoparticles; lyophilization; mRNA; mRNA immunogenicity; mRNA modifications; mRNA vaccines; saRNA

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google